Literature DB >> 9043940

Vancomycin down-regulates lipopolysaccharide-induced tumour necrosis factor alpha (TNF alpha) production and TNF alpha-mRNA accumulation in human blood monocytes.

M Siedlar1, A Szczepanik, J Wieckiewicz, A Pituch-Noworolska, M Zembala.   

Abstract

The cytokines play an important role in the cascade of the pathological events leading to septic shock. The TNF alpha produced by monocytes/macrophages upon stimulation with bacterial fragments may contribute to induction of this cytokine cascade. Moreover, the antibiotics used for antimicrobial therapy may cause the increase of TNF alpha production due to massive bacterial killing and exposure of monocytes/macrophages to bacterial cell constituents. To investigate the effect of Vancomycin on TNF alpha production, an in vitro model of LPS-stimulated monocytes was used. The level of TNF alpha protein or TNF biological activity were tested in the culture supernatants of monocytes with LPS. Vancomycin down-regulated, in dose-dependent manner, the TNF alpha production. Vancomycin also inhibited TNF alpha-mRNA accumulation in LPS-stimulated monocytes, as assessed by fluorescence in situ hybridization (FISH) in cell suspension. The down-regulation of TNF alpha production in LPS-stimulated monocytes may indicate that inhibition of this cytokine release is one of the important therapeutic effects of Vancomycin in sepsis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9043940     DOI: 10.1016/s0162-3109(96)00156-7

Source DB:  PubMed          Journal:  Immunopharmacology        ISSN: 0162-3109


  8 in total

1.  Immunomodulatory effect of vancomycin on Treg in pediatric inflammatory bowel disease and primary sclerosing cholangitis.

Authors:  David N Abarbanel; Scott M Seki; Yinka Davies; Natalie Marlen; Joseph A Benavides; Kathleen Cox; Kari C Nadeau; Kenneth L Cox
Journal:  J Clin Immunol       Date:  2012-10-09       Impact factor: 8.317

2.  Effect of empiric antibiotic treatment on plasma endotoxin activity in septic patients.

Authors:  F Mignon; M Piagnerelli; M Van Nuffelen; J L Vincent
Journal:  Infection       Date:  2014-01-28       Impact factor: 3.553

3.  Presence of functional TLR2 and TLR4 on human adipocytes.

Authors:  Sandrine Bès-Houtmann; Régis Roche; Laurence Hoareau; Marie-Paule Gonthier; Franck Festy; Henri Caillens; Philippe Gasque; Christian Lefebvre d'Hellencourt; Maya Cesari
Journal:  Histochem Cell Biol       Date:  2006-09-19       Impact factor: 4.304

4.  Therapeutic Effects of Intravitreously Administered Bacteriophage in a Mouse Model of Endophthalmitis Caused by Vancomycin-Sensitive or -Resistant Enterococcus faecalis.

Authors:  Tatsuma Kishimoto; Waka Ishida; Ken Fukuda; Isana Nakajima; Takashi Suzuki; Jumpei Uchiyama; Shigenobu Matsuzaki; Daisuke Todokoro; Masanori Daibata; Atsuki Fukushima
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

5.  Vancomycin Is Protective in a Neonatal Mouse Model of Staphylococcus epidermidis-Potentiated Hypoxic-Ischemic Brain Injury.

Authors:  Jacqueline C Y Lai; Pernilla Svedin; C Joakim Ek; Amin Mottahedin; Xiaoyang Wang; Ofer Levy; Andrew Currie; Tobias Strunk; Carina Mallard
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

6.  Linezolid and vancomycin decrease the therapeutic effect of methylene blue-photodynamic therapy in a mouse model of MRSA bacterial arthritis.

Authors:  Masamitsu Tanaka; Pawel Mroz; Tianhong Dai; Liyi Huang; Yuji Morimoto; Manabu Kinoshita; Yasuo Yoshihara; Nariyoshi Shinomiya; Shuhji Seki; Koichi Nemoto; Michael R Hamblin
Journal:  Photochem Photobiol       Date:  2013-02-19       Impact factor: 3.421

7.  Toll-Like Receptor 4 Signaling in High Mobility Group Box-1 Protein 1 Mediated the Suppression of Regulatory T-Cells.

Authors:  Chunyan Luo; Huiting Liu; Hu Wang; Jiajun Wang
Journal:  Med Sci Monit       Date:  2017-01-18

8.  Successful treatment of recurrent primary sclerosing cholangitis after orthotopic liver transplantation with oral vancomycin.

Authors:  Yinka K Davies; Cynthia J Tsay; Dario V Caccamo; Kathleen M Cox; Ricardo O Castillo; Kenneth L Cox
Journal:  Case Rep Transplant       Date:  2013-02-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.